TrialPloS one2021
Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
Makoto Hiki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it
TrialPloS one2021
Makoto Hiki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.